Latest News and Press Releases
Want to stay updated on the latest news?
-
SCOTTSDALE, Ariz., May 19, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company focused on...
-
MIAMI, May 18, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term...
-
New York, New York, May 11, 2026 (GLOBE NEWSWIRE) -- Starlink AI Acquisition Corporation, a blank check company incorporated in the Cayman Islands as an exempted company with limited liability (the...
-
Aptera Motors (NASDAQ: SEV) raises $6.3M via warrant inducement to fund solar EV manufacturing and testing.
-
Aptera (NASDAQ: SEV) closes $9M public offering with warrants for up to $18M total, advancing solar electric vehicle production and validation efforts.
-
Aptera today announced the pricing of its public offering for the purchase and sale of 4,500,000 shares of its Class B common stock.
-
Aptera announced today that Co-CEO Chris Anthony will participate in A.G.P.’s Annual Virtual Electric Vehicles and Transportation Conference.
-
HANOVER, MD, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...
-
MIAMI, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused on acquiring and advancing assets to...
-
MIAMI, May 16, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term...